Holders over time
- TMO
- GILD
| Quarter | TMO | GILD |
|---|---|---|
| Q4 2020 | 33 holders, $39.2bn | 27 holders, $13.4bn |
| Q1 2021 | 35 holders, $36.5bn | 24 holders, $14.5bn |
| Q2 2021 | 33 holders, $38.3bn | 18 holders, $14.9bn |
| Q3 2021 | 32 holders, $42.6bn | 20 holders, $16.4bn |
| Q4 2021 | 38 holders, $50.1bn | 20 holders, $16.8bn |
| Q1 2022 | 32 holders, $43.2bn | 28 holders, $13.2bn |
| Q2 2022 | 33 holders, $38.9bn | 26 holders, $13.6bn |
| Q3 2022 | 26 holders, $34.3bn | 24 holders, $13.3bn |
| Q4 2022 | 29 holders, $37.0bn | 32 holders, $21.1bn |
| Q1 2023 | 35 holders, $37.1bn | 27 holders, $21.8bn |
| Q2 2023 | 39 holders, $33.5bn | 24 holders, $20.7bn |
| Q3 2023 | 39 holders, $32.6bn | 24 holders, $20.0bn |
| Q4 2023 | 41 holders, $32.7bn | 22 holders, $21.5bn |
| Q1 2024 | 30 holders, $34.1bn | 30 holders, $20.3bn |
| Q2 2024 | 38 holders, $30.6bn | 28 holders, $18.5bn |
| Q3 2024 | 30 holders, $33.8bn | 29 holders, $24.2bn |
| Q4 2024 | 36 holders, $27.6bn | 28 holders, $25.9bn |
| Q1 2025 | 31 holders, $24.2bn | 33 holders, $32.0bn |
| Q2 2025 | 39 holders, $18.8bn | 27 holders, $30.9bn |
| Q3 2025 | 32 holders, $21.9bn | 23 holders, $29.4bn |
| Q4 2025 | 32 holders, $29.9bn | 25 holders, $34.3bn |
| Q1 2026 | 34 holders, $24.4bn | 25 holders, $38.5bn |
| Q2 2026 | 36 holders, $26.4bn | 26 holders, $34.2bn |
| Q3 2026 | 35 holders, $40.3bn | 31 holders, $38.6bn |
Thermo Fisher Scientific Inc
- Holders
- 30
- Reported value
- $34.1bn
- Buyers
- 14
- Sellers
- 18
Breadth -4 among 93 comparable managers.
Gilead Sciences Inc
- Holders
- 30
- Reported value
- $20.3bn
- Buyers
- 17
- Sellers
- 12
Breadth +5 among 93 comparable managers.
Who holds both, Q1 2024
Both (15)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Capital Research Global Investors, Capital World Investors, Dodge & Cox, Fidelity (FMR LLC), Invesco Ltd, Janus Henderson Group Ltd, Neuberger Berman Group LLC, Point72 Asset Management LP, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Two Sigma Investments LP, Wellington Management Group LLP
Only TMO (15)
Baillie Gifford & Co, ExodusPoint Capital Management LP, Farallon Capital Management LLC, GAMCO Investors Inc, Holocene Advisors LP, Markel Group Inc, Maverick Capital Ltd, MFS Investment Management, Moore Capital Management LP, Polen Capital Management LLC, Quantbot Technologies LP, Steadfast Capital Management LP, TCI Fund Management Ltd, Verition Fund Management LLC, Viking Global Investors LP
Only GILD (15)
Arrowstreet Capital LP, Bridgewater Associates LP, Caxton Associates LLP, Citadel Advisors LLC, D. E. Shaw & Co., Eisler Capital Management Ltd, Hudson Bay Capital Management LP, Man Group PLC, Renaissance Technologies LLC, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, Tudor Investment Corp, Voloridge Investment Management LLC, Winton Group Ltd, Woodline Partners LP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.